Alan Lee Bazaar

Board Director

Director

Wireless Telecom Group IncOrthofix Medical Inc.FOX Factory Holding Corp

Insider activity · 24 months2 buys0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 1 buy · 0 salesJun 25 · 1 buy · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€44k

▼ Sales (0 ops.)

—

Latest filing published 12 Jun 2026 for Orthofix Medical Inc.. Read the official filing

Filing timeline

BuySale

Alan Lee Bazaar

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

100%

T+90 mean return

+33.2%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Alan Lee Bazaar: trading record in brief

This profile gathers the share dealings of Alan Lee Bazaar across 3 companies, led by Orthofix Medical Inc., Wireless Telecom Group Inc and FOX Factory Holding Corp. In total, 13 filings cover trades dated from 2 August 2021 to 10 June 2026.

No open-market sale appears; the market trades are 2 purchases worth €44k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 9 share grants.

The record was last updated on 12 June 2026 with a share grant in Orthofix Medical Inc. The last insider purchase was made public on 5 June 2025, 500 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.